Endovia Health Sciences, Inc. (SBEV) intrinsic value & 10-year financials
Endovia Health Sciences, Inc. (SBEV) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 25.3% a year to $73.1K, with an average return on invested capital of 140.9%.
- Graham intrinsic value
- —
- Revenue (FY2025)
- $73.1K
- Revenue growth (10-yr CAGR)
- -25.3%
- ROIC (10-yr avg)
- 140.9%
- Free cash flow (FY2025)
- —
SBEV 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $73.1K | -$25.2M | -$11.97 | — | -19415.6% | 88.1% |
| FY2024 | $4.2M | -$23.8M | -$17.68 | -$8.0M | -386.2% | 146.8% |
| FY2023 | $18.9M | -$21.0M | — | -$10.2M | -81.1% | -1142.6% |
| FY2022 | $18.1M | -$21.7M | — | -$14.2M | -118.3% | -321.0% |
| FY2021 | $11.3M | -$29.1M | -$1.02 | -$14.6M | -257.0% | 1913.0% |
| FY2020 | $3.0M | -$28.7M | -$1.06 | -$21.4M | -581.4% | 396.7% |
| FY2019 | $1.0M | -$477.2K | -$0.04 | -$282.8K | -46.2% | 79.5% |
| FY2018 | $1.3M | $68.2K | $0.01 | -$13.2K | 5.1% | -13.4% |
| FY2017 | $895.3K | -$147.5K | — | -$75.9K | -17.6% | 613.5% |
| FY2016 | $1.0M | -$48.8K | — | -$26.3K | -4.9% | -351.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SPLASH BEVERAGE GROUP, INC. is facing top-line stagnation, with revenue contracting over the decade.
SPLASH BEVERAGE GROUP, INC. has earned high returns on invested capital, averaging 31.2% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
SPLASH BEVERAGE GROUP, INC. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SPLASH BEVERAGE GROUP, INC. is modeled at -25.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.36 per share.